Cargando…

Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas

Detalles Bibliográficos
Autores principales:	Kocakavuk, Emre, Johnson, Kevin C, Sabedot, Thais S, Reinhardt, Hans Christian, Noushmehr, Houtan, Verhaak, Roel G W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479907/ https://www.ncbi.nlm.nih.gov/pubmed/37329568 http://dx.doi.org/10.1093/neuonc/noad095

Ejemplares similares

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

OMRT-3. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment
por: Varn, Frederick, et al.
Publicado: (2021)

RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes
por: Mall, Raghvendra, et al.
Publicado: (2018)

Radiotherapy is associated with a deletion signature that contributes to poor outcomes in cancer patients
por: Kocakavuk, Emre, et al.
Publicado: (2021)

Noninvasive approaches to detect methylation-based markers to monitor gliomas
por: Noushmehr, Houtan, et al.
Publicado: (2022)

Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2007)

A catalog of hemizygous variation in 127 22q11 deletion patients
por: Hestand, Matthew S, et al.
Publicado: (2016)

Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021)

OR24-5 Aberrant DNA Methylation in Regulatory Genomic Elements Are Associated with Invasive Behavior of Pituitary Macroadenomas: An Integrative Analysis of Epigenome-Wide Studies
por: Mosella, Maritza, et al.
Publicado: (2019)

ODP653 DNA Methylation Markers Detected in Liquid Biopsy Specimens Differentiate Pituitary Neuroendocrine Tumors from Other Sellar and CNS Diseases
por: Castro, Ana Valeria, et al.
Publicado: (2022)

Hemizygous deletion in the OTC gene results in ornithine transcarbamylase deficiency: A case report
por: Wang, Li-Ping, et al.
Publicado: (2022)

Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis
por: Datta, Indrani, et al.
Publicado: (2021)

SIRT1 regulates Mxd1 during malignant melanoma progression
por: Meliso, Fabiana M., et al.
Publicado: (2017)

Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma
por: Huang, L. Eric
Publicado: (2022)

Characterization of hemizygous deletions in Citrus using array-Comparative Genomic Hybridization and microsynteny comparisons with the poplar genome
por: Ríos, Gabino, et al.
Publicado: (2008)

Brachytelephalangic chondrodysplasia punctata caused by new small hemizygous deletion in a boy presenting with hearing loss
por: Vrečar, Irena, et al.
Publicado: (2015)

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
por: Colaprico, Antonio, et al.
Publicado: (2016)

P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
por: Vij, Meenakshi, et al.
Publicado: (2023)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

TBMT-02. APOLLO: RAMAN-BASED PATHOLOGY OF MALIGNANT GLIOMA
por: Lita, Adrian, et al.
Publicado: (2021)

Unmet need for liquid biomarkers and the Brain-Liquid Biopsy Consortium
por: Short, Susan C, et al.
Publicado: (2022)

Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series
por: Malt, Eva Albertsen, et al.
Publicado: (2019)

VarGenius-HZD Allows Accurate Detection of Rare Homozygous or Hemizygous Deletions in Targeted Sequencing Leveraging Breadth of Coverage
por: Musacchia, Francesco, et al.
Publicado: (2021)

PCDH19 in Males: Are Hemizygous Variants Linked to Autism?
por: Chouery, Eliane, et al.
Publicado: (2023)

Hemizygous Deletion on Chromosome 3p26.1 Is Associated with Heavy Smoking among African American Subjects in the COPDGene Study
por: Begum, Ferdouse, et al.
Publicado: (2016)

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014)

Reconstructing the molecular life history of gliomas
por: Barthel, Floris P., et al.
Publicado: (2018)

Glioma: experimental models and reality
por: Lenting, Krissie, et al.
Publicado: (2017)

TP53 Mutations in Myeloid Malignancies are either Homozygous or Hemizygous due to Copy Number-Neutral Loss of Heterozygosity or Deletion of 17p
por: Jasek, Monika, et al.
Publicado: (2009)

Distinct features of the Leishmania cap-binding protein LeishIF4E2 revealed by CRISPR-Cas9 mediated hemizygous deletion
por: Baron, Nofar, et al.
Publicado: (2021)

A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence
por: de Souza, Camila Ferreira, et al.
Publicado: (2018)

Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma
por: Wang, Haiwei, et al.
Publicado: (2021)

Nfib hemizygous mice are protected from hyperoxic lung injury and death
por: Kumar, Vasantha H. S., et al.
Publicado: (2017)

Novel hemizygous nonsense mutation in DRP2 is associated with inherited neuropathy
por: Roda, Ricardo H., et al.
Publicado: (2018)

Congenital Myasthenic Syndrome Caused by a Novel Hemizygous CHAT Mutation
por: Zhang, Yixia, et al.
Publicado: (2020)

Hemizygous FLNA variant in West syndrome without periventricular nodular heterotopia
por: Hiromoto, Yoshitaka, et al.
Publicado: (2020)

CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data
por: Wach, Johannes, et al.
Publicado: (2023)

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_npi048ga8vsh97em4cj8du73vc